{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20230516",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20180411",
          "review_priority": "STANDARD",
          "submission_class_code": "UNKNOWN"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "6",
          "submission_status": "AP",
          "submission_status_date": "20230516",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20230516",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling"
        }
      ],
      "application_number": "ANDA206077",
      "sponsor_name": "FRESENIUS KABI USA",
      "openfda": {
        "application_number": [
          "ANDA206077"
        ],
        "brand_name": [
          "DAPTOMYCIN"
        ],
        "generic_name": [
          "DAPTOMYCIN"
        ],
        "manufacturer_name": [
          "Fresenius Kabi USA, LLC"
        ],
        "product_ndc": [
          "63323-371"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "DAPTOMYCIN"
        ],
        "rxcui": [
          "403920"
        ],
        "spl_id": [
          "7b38aacb-d9c9-47db-a6fe-7e7d938fcd69",
          "b1854217-71fa-48a4-9279-928e663eb5ec"
        ],
        "spl_set_id": [
          "a990141d-7b92-48a5-a41d-1254522e2aa1",
          "fa514937-e025-4ea7-b62a-385eb056ae70"
        ],
        "package_ndc": [
          "63323-371-10",
          "63323-371-19"
        ],
        "nui": [
          "N0000175509",
          "M0519359"
        ],
        "pharm_class_epc": [
          "Lipopeptide Antibacterial [EPC]"
        ],
        "pharm_class_cs": [
          "Lipopeptides [CS]"
        ],
        "unii": [
          "NWQ5N31VKK"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "DAPTOMYCIN",
          "active_ingredients": [
            {
              "name": "DAPTOMYCIN",
              "strength": "500MG/VIAL"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "POWDER",
          "route": "INTRAVENOUS",
          "marketing_status": "Prescription",
          "te_code": "AP"
        }
      ]
    }
  ]
}